Lead investigational asset vidutolimod is a potential best-in-class TLR9 agonist, with demonstrated clinical responses observed in PD-1 refractory melanoma as monotherapy Vidutolimod is currently ...
The Peacemaker Season 2 finale had some shocking moments, including a finale that saw the titular hero very far from home. However, it also introduced a new covert organization straight out of DC ...
Proposed ~$250 million all-cash acquisition strengthens Regeneron's portfolio of diverse and combinable immuno-oncology candidates Lead investigational asset vidutolimod is a potential best-in-class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results